Description/Abstract: Current oncology operates on the wrong side of a phase transition. The field studies cancer as a disease beginning with malignant cells, treating those cells as the cause of the disease and their elimination as the cure. This paper proposes that cancer is not a disease beginning with malignant cells but a fractal emergent phenomenon — the output of a complex nonlinear biological system crossing a critical phase transition threshold. Malignant cells are the emergent property, not the cause. The cause is the accumulating systemic complexity that drives the biological system toward its critical transition point. This reframing generates a specific, testable prediction: if cancer is a phase transition, then the universal precursor signatures of critical transitions — critical slowing down, increased variance, flickering, and distributional skewness — should be detectable in pre-malignant tissue before any histological abnormality appears. The paper identifies the cGAS-STING DNA damage sensing pathway as a candidate keypoint vector for detecting these signatures, resolves the documented "paradox" of STING's dual pro- and anti-tumorigenic effects as a natural consequence of phase transition dynamics, and proposes a Dynamic Biomarker Monitoring (DBM) paradigm that replaces static single-value biomarkers with time-series analysis of critical transition signatures. The framework extends beyond cancer to all emergent diseases, revitalizes general practice medicine as the apex of a preventive healthcare system, bridges Eastern and Western medical philosophies through rigorous mathematics, and provides an economic self-stabilization model for the transition from reactive to preventive medicine. The theory is the test: the prediction specifies the exact measurement, the exact analysis, and the exact falsification criterion, using existing instruments and established mathematics. No new technology is required. Only a new lens. Keywords: cancer, fractal emergence, phase transition, critical transition signatures, dynamic biomarkers, cGAS-STING, pre-transition detection, complexity mathematics, preventive medicine, nonlinear dynamics, early warning signals, oncology
Lucian Randolph (Sun,) studied this question.